In conclusion, we have demonstrated that triazole derivatives are reversible, potent and selective inhibitors of cathepsin X, a peptidase identified as a target for the treatment of cancer and neurodegenerative diseases. This evidence concerns the gene CTSK and neurodegenerative disease.